On Monday, June 13th, Dr. A. Mark Fendrick, Director of the Center for Value-Based Insurance Design (V-BID), spoke at the China-US Precision Medicine Industry and Policy Forum. The Forum is part of a larger event, titled “The Fourth Shenzhen International Low Carbon City Forum,” and took place in Shenzhen, Guangdong Province, China. Dr. Fendrick also participated in an additional roundtable event held on Sunday, June 12th.
The event will bring together health economists and policy stakeholders to discuss the opportunities and challenges of using genomic science to improve the quality and efficiency of health care and public health services delivery in China and internationally. Dr. Fendrick will discuss V-BID in the context of the Chinese health system and precision medicine.
Dr. Fendrick’s presentation, including the Chinese translation, can be found below.
Dr. Fendrick presenting about the key tenets of V-BID strategy in China.
Dr. Fendrick presenting Dr. Jian Wang, CEO of Beijing Genomics Institute, with a V-BID t-shirt.
Dr. Jian Wang, CEO of Beijing Genomics Institute, presenting in his V-BID t-shirt.
Dr. Fendrick and Vice Mayor Jie Tang of Shenzhen.
